Publicaciones destacadas

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

Llovet, Josep M; Willoughby, Catherine E; Singal, Amit G; Greten, Tim F; Heikenwaelder, Mathias;

El-Serag, Hashem B; Finn, Richard S; Friedman, Scott L.

Referencia:
Nature Reviews Gastroenterology & Hepatology 2023.
International Liver cancer Association (ILCA) White Paper on Hepatocellular carcinoma Risk Stratification and Surveillance

Singal, AG; Hoshida, Y; Rich, N; Sanduzzi-Zamparelli, M; Reig, M;

(...)

Vilgrain, V; Marrero, J; Llovet, JM; Villanueva, A; Parikh, ND.

Referencia:
Journal Of Hepatology 2023.
Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma

Haber PK; Castet F; Torres-Martin M; Andreu-Oller C; Puigvehí M;

(...)

Finn RS; Thung S; Villanueva A; Sia D; Llovet JM.

Referencia:
Gastroenterology 2023.
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

Montironi, C; Castet, F; Pinyol, R; Torres-Martin, M; Fontanals, LT;

(...)

Neely, J; Anderson, J; Mazzaferro, V; Roayaie, S; Sia, D.

Referencia:
Gut 2023.
Immunotherapies for hepatocellular carcinoma

Llovet, Josep M; Castet, Florian; Heikenwalder, Mathias; Maini, Mala K; Mazzaferro, Vincenzo;

Pinato, David J; Pikarsky, Eli; Zhu, Andrew X; Finn, Richard S.

Referencia:
Nature Reviews Clinical Oncology 2022.
Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Pinyol, R; Torrecilla, S; Montironi, C; Piqué-Gili, M; Torres-Martin, M;

(...)

Roessler, S; Schirmacher, P; Minguez, B; Reeves, HL; Sanyal, A.

Referencia:
Journal Of Hepatology 2021.
NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Pfister, D; Szydlowska, M; Müller, F; Heide, D; Stirm, K;

(...)

Zender, L; Marche, PN; Decaens, T; Jilkova, ZM; Pinato, DJ.

Referencia:
Nature 2021.
Hepatocellular carcinoma

Llovet, JM; Villanueva, A; Kelley, RK; Singal, AG; Pikarsky, E;

Roayaie, S; Lencioni, R; Koike, K; Zucman-Rossi, J; Finn, RS.

Referencia:
Nature Reviews Disease Primers 2021.
Sorafenib in Advanced Hepatocellular Carcinoma

Llovet, JM; Ricci, S; Mazzaferro, V; Hilgard, P; Gane, E;

(...)

Giannaris, T; Shan, M; Moscovici, M; Voliotis, D; Bruix, J.

Referencia:
New England Journal Of Medicine 2008.
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

Hoshida, Yujin; Villanueva, Augusto; Kobayashi, Masahiro; Peix, Judit; Chiang, Derek Y;

(...)

Bruix, Jordi; Friedman, Scott L; Kumada, Hiromitsu; Llovet, Josep M; Golub, Todd R.

Referencia:
New England Journal Of Medicine 2008.